Friday, December 18, 2009

Of John Carter, CV 247 and curing cancer in dogs (and humans)

Years ago I remember reading something about a vet in Harrow who was having great success in treating cancer in pets (and humans!) but I never gave it much thought until one of our customers recently wrote and pointed out that part of the treatment was a raw, organic diet. So I did a little research and found that the vet concerned was called John Carter - sadly now deceased - and that his work had had quite a bit of publicity and is now (after many years of struggling) available in Hungary. As Hungary is in the EU I think this may mean the treatment is available here. Anyway, the website of the company which was set up to develop and research the treatment Ivy Medical Chemicals ( is fascinating. Here is what they say about CV 247:

"CV 247 is a combination product comprising of Sodium Salicylate, Copper Gluconate, Manganese Gluconate and Ascorbic Acid (Vitamin C) taken as a solution. The product was conceived and initially developed by Mr John Carter, veterinary surgeon, who also advocated that in combination with the therapy a patient also followed an “organic Diet”.

Mr Carter established the treatment regime after many years of study and empirical research starting in around 1976. The work began after a number of friends and associates as well as many companion animals had succumbed to the effects of cancer. Mr Carter’s hypothesis was that the increasing rate of cancer affecting the human and animal world could have an association with modern food manufacturing methods and the environment. His theory and treatment was aimed at stimulating the individual’s immune system so as to resist the development or progression of cancer. The effect of this theory was repeatedly tested in his Veterinary practice on a compassionate treatment basis. Mr Carter’s interest and the success with the animals he treated led to word of mouth recommendations to tend to other animals suffering from cancer.

CV 247 was seen by pet owners to have a notable rate of success on their respective companion animals, and an anecdotal portfolio of satisfied dog owners was compiled. Credibility in the drug and treatment regime increased further when in 1993 Mr Carter was introduced to UCL Ventures, a division of University College London (UCLV). The anecdotal evidence collected persuaded UCLV that the claim should be investigated independently. UCLV agreed to carry out controlled trials and introduced Professor Peter Beverly who at that time was Head of the Tumour Immunology Unit of the Imperial Cancer Fund at University College London. Professor Beverly agreed to undertake a series of controlled experiments on the effect of the treatment on malignant cancers in mice. After gaining the necessary licence to undertake the experiment, the trials were carried out under a formal contract between John Carter and UCL.

Three controlled experiments were carried out. Professor Beverly concluded in his report that the treatment caused a statistically significantly reduction in the rate of tumour growth in the treated compared to the untreated groups and that there were no observable side effects attributed to the treatment."

You'll find tons more on the web about all of this. I don't feel qualified to say anything about the efficacy of the treatment but if I hear of any dog or person suffering from cancer I shall certainly pass the details on. Incidentally, I have a feeling that I read somewhere that you have to start treatment before chemotherapy.


  1. Many vets (and some doctors)in the UK are now prescribing CV247 - check out Beverley Cuddy's blog dedicated to CV247 for more info. and a list of vets:
    (Beverley is the editor of Dogs Today magazine)

  2. I don't understand how the lack of sensitive people is every time more often in the world. They terminate the life of dogs that suffer from cancer, but sometimes they do it wrongly. Generic Viagra is such a good remedy for dealing with the erection problems of men, it's too bad that dogs can't enjoy the same medicament as well.